Abstract:Silicosis is a long-established public health issue in developing countries due to increasingly serious air pollution and poorly implemented occupational safety regulation. Inhalation of silica triggers cytotoxicity, oxidative stress, pulmonary inflammation and eventually silicosis. Current understanding in the pathogenesis and mechanism of silicosis is limited, and no effective cure is clinically available once silicosis is developed. A number of studies were conducted to investigate silica-induced alternate gene expressions in pulmonary cells. However, transcriptome analysis in a silicosis animal model is needed. This study was performed to evaluate the transcriptional alternations in silicotic mice using comparative RNA-Seq. A silicosis mice model was established by intratracheal instillation of silica suspensions, and validated by histological examinations. High-throughput sequencing and differential gene expression analysis revealed 749 upregulated genes and 70 downregulated genes in the silicosis model. Genes related to immune cell interactions, immune cell responses and inflammation were significantly enriched. Cytokine-cytokine receptor interaction and downstream JAK-STAT signaling pathways were the most significantly enriched KEGG pathways. Reverse transcription-polymerase chain reaction analysis and immunohistochemistry were performed to validate further the differential expression patterns of representative genes. The reported results in this study provide the basis for elucidating the molecular mechanisms for silica-induced pulmonary inflammation and fibrosis, and support the prevention and treatment of silicosis. Silicosis mice model was established by intra-tracheal instillation of silica suspensions. High-throughput RNA-Seq and DGE analysis revealed 749 up-regulated and 70 down-regulated genes. Genes related to immune cell interactions, immune cell responses and inflammation were significantly enriched. Cytokine-cytokine receptor interaction and down-stream JAK-STAT signalling pathways were significantly enriched KEGG pathways. The reported results in this study provide basis for elucidating the molecular mechanisms for silica induced pulmonary inflammation and fibrosis, and support the prevention and treatment of silicosis.

Animal models of silicosis: fishing for new therapeutic targets and treatments

Progress in experimental animal models of silicosis

Zebrafish models of COVID-19

Integrative transcriptomic and proteomic analysis reveals mechanisms of silica-induced pulmonary fibrosis in rats

Comparative RNA-Seq transcriptome analysis on silica induced pulmonary inflammation and fibrosis in mice silicosis model.

Animal models of human disease: zebrafish swim into view

Zebrafish in Lung Cancer Research.

The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease

Modeling Inflammation in Zebrafish for the Development of Anti-inflammatory Drugs

New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis

Comparative Transcriptome Analyses Reveal a Transcriptional Landscape of Human Silicosis Lungs and Provide Potential Strategies for Silicosis Treatment

Zebrafish as an animal model of human disease

Lung decellularized matrix-derived 3D spheroids: Exploring silicosis through the impact of the Nrf2/Bax pathway on myofibroblast dynamics

Zebrafish Models for Skeletal and Extraskeletal Osteogenesis Imperfecta Features: Unveiling Pathophysiology and Paving the Way for Drug Discovery

Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration

Zebrafish as an animal model for biomedical research

Zebrafish: An emerging model system to study liver diseases and related drug discovery

Proteome, Lysine Acetylome, and Succinylome Identify Posttranslational Modification of STAT1 as a Novel Drug Target in Silicosis

Insights from the Zebrafish Model

A novel pathophysiological classification of silicosis models provides some new insights into the progression of the disease

Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease